---
figid: PMC4411176__nihms680218f1
figlink: /pmc/articles/PMC4411176/figure/F1/
number: F1
caption: A. Oligosaccharide Glc3Man9GlcNAc2 (G3M9) is transferred to Asn residues
  on nascent polypeptides by oligosaccharyltransferase. Lettering a–n indicates the
  order of addition of the monosaccharides during in vivo synthesis of the Dolichol-PP-Glc3Man9GlcNAc2
  precursor. Arm A, B and C indicate the oligosaccharide branch. During biosynthesis
  residues a–g are added on the cytosolic face of the ER membrane from nucleotide-sugar
  precursors, while residues h–n are added from Dol-P-Glc or Dol-P-Man precursors
  after the oligosaccharide has flipped across the membrane. B. After glycan transfer
  to proteins, Glucosidase I (GI) removes glucose n, Glucosidase II (GII) removes
  glucose m and l, and UDP-Glc:glycoprotein glucosyltransferase (UGGT) adds glucose
  l. ER mannosidases may remove mannoseI and k. Monoglucosylated N-glycans are able
  to interact with ER lectins calnexin (CNX) and/or calreticulin (CRT). ER mannosidase
  I (ERManI) (MNSI in yeasts) acts as a timer of permanence of glycoproteins in the
  ER and removes residue I generating M8B. Subsequently, ERManI or other ER mannosidases
  (probably EDEM in mammals or Htm1in yeasts) may remove residue k, generating M7.
  Demannosylated glycans constitute the ERAD signal. Dotted lines are used to indicate
  that GII activity is reduced toward demmanosylated species.
pmcid: PMC4411176
papertitle: Glucosidase II and MRH-domain containing proteins in the secretory pathway.
reftext: Cecilia D’Alessio, et al. Curr Protein Pept Sci. ;16(1):31-48.
pmc_ranked_result_index: '190415'
pathway_score: 0.8727747
filename: nihms680218f1.jpg
figtitle: Glucosidase II and MRH-domain containing proteins in the secretory pathway
year: ''
organisms: Homo sapiens
ndex: 3577eaf3-df15-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4411176__nihms680218f1.html
  '@type': Dataset
  description: A. Oligosaccharide Glc3Man9GlcNAc2 (G3M9) is transferred to Asn residues
    on nascent polypeptides by oligosaccharyltransferase. Lettering a–n indicates
    the order of addition of the monosaccharides during in vivo synthesis of the Dolichol-PP-Glc3Man9GlcNAc2
    precursor. Arm A, B and C indicate the oligosaccharide branch. During biosynthesis
    residues a–g are added on the cytosolic face of the ER membrane from nucleotide-sugar
    precursors, while residues h–n are added from Dol-P-Glc or Dol-P-Man precursors
    after the oligosaccharide has flipped across the membrane. B. After glycan transfer
    to proteins, Glucosidase I (GI) removes glucose n, Glucosidase II (GII) removes
    glucose m and l, and UDP-Glc:glycoprotein glucosyltransferase (UGGT) adds glucose
    l. ER mannosidases may remove mannoseI and k. Monoglucosylated N-glycans are able
    to interact with ER lectins calnexin (CNX) and/or calreticulin (CRT). ER mannosidase
    I (ERManI) (MNSI in yeasts) acts as a timer of permanence of glycoproteins in
    the ER and removes residue I generating M8B. Subsequently, ERManI or other ER
    mannosidases (probably EDEM in mammals or Htm1in yeasts) may remove residue k,
    generating M7. Demannosylated glycans constitute the ERAD signal. Dotted lines
    are used to indicate that GII activity is reduced toward demmanosylated species.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARMC9
  - THRA
  - GPR162
  - GNAT1
  - GNAT2
  - GNAI3
  - GNAO1
  - EDEM1
  - GNAI2
  - GNAZ
  - CANX
  - GNAT3
  - THRB
  - CALR
  - GNAI1
  - Thr
genes:
- word: Arm
  symbol: ARM
  source: hgnc_alias_symbol
  hgnc_symbol: ARMC9
  entrez: '80210'
- word: AsnXSer/Thr-
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: a1,2
  symbol: A-2
  source: hgnc_alias_symbol
  hgnc_symbol: GPR162
  entrez: '27239'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: EDEM
  symbol: EDEM
  source: hgnc_alias_symbol
  hgnc_symbol: EDEM1
  entrez: '9695'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: CNX/CRTfavoring
  symbol: CNX
  source: hgnc_alias_symbol
  hgnc_symbol: CANX
  entrez: '821'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: AsnXSer/Thr-
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: CNX/CRT
  symbol: CRT
  source: hgnc_alias_symbol
  hgnc_symbol: CALR
  entrez: '811'
- word: GI
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
chemicals:
- word: Thr
  source: MESH
  identifier: D013912
diseases: []
figid_alias: PMC4411176__F1
redirect_from: /figures/PMC4411176__F1
figtype: Figure
---
